๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

20 recruiting trials

for Relapsed Pediatric AML

PLAT-08: A Study Of SC-DARIC33 CAR T Cells In Pediatric And Young Adults With Relapsed Or Refractory CD33+ AML NCT05105152Phase 11 site๐Ÿ“ Seattle Seattle Children's Hospital ยท Tests: SC-DARIC33 HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant NCT03326921Phase 11 site๐Ÿ“ Seattle Fred Hutchinson Cancer Center ยท Tests: CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR, Bone Marrow Aspiration, Biospecimen Collection Niclosamide in Pediatric Patients With Relapsed and Refractory AML NCT05188170Phase 11 site๐Ÿ“ Palo Alto Stanford University ยท Tests: Niclosamide Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling NCT05857969Phase 11 site๐Ÿ“ Miami Florida International University ยท Tests: Functional Precision Medicine A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) NCT07306832Phase 114 sites๐Ÿ“ Palo Alto๐Ÿ“ Atlanta๐Ÿ“ Valhalla AbbVie ยท Tests: Pivekimab Sunirine The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study NCT04726241Phase 1, Phase 2184 sites๐Ÿ“ Birmingham๐Ÿ“ Mobile๐Ÿ“ Anchorage PedAL BCU, LLC ยท Tests: Biospecimen Collection Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation NCT06316960Phase 212 sites๐Ÿ“ Hefei๐Ÿ“ Hefei๐Ÿ“ Guangzhou Children's Hospital of Soochow University ยท Tests: Avapritinib, Azacitidine Injection, Decitabine Injection, Idarubicin Hydrochloride, Cytarabine FH-FOLR1 Chimeric Antigen Receptor T Cell Therapy for Treating Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia NCT06609928Phase 11 site๐Ÿ“ Seattle Fred Hutchinson Cancer Center ยท Tests: FOLR1 CAR T-cells, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Cyclophosphamide A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy NCT06247787Phase 119 sites๐Ÿ“ Birmingham๐Ÿ“ Orange๐Ÿ“ San Francisco Children's Oncology Group ยท Tests: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Cytarabine, Echocardiography Test Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution NCT06131801n/a6 sites๐Ÿ“ Aurora๐Ÿ“ Atlanta๐Ÿ“ Cincinnati Children's Hospital Medical Center, Cincinnati ยท Tests: 1. Drug: The Venetoclax PK study is collecting bodily fluid samples (ie., whole blood and optional cerebrospinal fluid)โ€ฆ A Phase Ia/Ib Open-label, Multiple Dose, Study to Determine the Recommended Dose, Evaluate PKs, PDs, Safety, and Activity of Venetoclax in Combination With Oral Decitabine/Cedazuridine (ASTX727) in Pediatric Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) NCT06191978Phase 11 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: ASTX727, Venetoclax Feasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Stem Cell Transplantation NCT07256210Phase 21 site๐Ÿ“ Moscow Federal Research Institute of Pediatric Hematology, Oncologโ€ฆ ยท Tests: Donor-derived Natural Killer Cell CARCIK CD123/33 for Refractory/Relapsed AML and BPDCN in Children and Adults NCT07877610Phase 1, Phase 22 sites๐Ÿ“ Monza๐Ÿ“ Bergamo Fondazione Matilde Tettamanti Menotti De Marchi Onlus ยท Tests: CARCIK CD123/33 infusion Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy NCT05101551Phase 19 sites๐Ÿ“ Phoenix๐Ÿ“ Little Rock๐Ÿ“ Duarte Norman J. Lacayo ยท Tests: Talazoparib, Topotecan, Gemcitabine Vyxeosยฎ With Clofarabine for Pediatric AML NCT07156435Phase 113 sites๐Ÿ“ Vienna๐Ÿ“ Copenhagen๐Ÿ“ Augsburg Princess Maxima Center for Pediatric Oncology ยท Tests: Vyxeos 44 MG / 100 MG Liposome Injection, Clofarabine Using Multiparametric Flow Cytometry to Detect Peripheral Blood and Bone Marrow Leukaemia Stem Cells for Relapse Prediction in P-AML NCT06452732n/a2 sites๐Ÿ“ Beijing๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: MFC for the determination of leukemia stem cell Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors NCT02508038Phase 11 site๐Ÿ“ Madison University of Wisconsin, Madison ยท Tests: TCRฮฑฮฒ+/CD19+ depleted Haploidentical HSCT, Zoledronate Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies NCT05476770Phase 131 sites๐Ÿ“ Los Angeles๐Ÿ“ Orange๐Ÿ“ San Francisco Therapeutic Advances in Childhood Leukemia Consortium ยท Tests: Tagraxofusp, Fludarabine, Cytarabine, Dexamethasone, Vincristine Venetoclax to Augment Epigenetic Modification and Chemotherapy NCT05317403Phase 11 site๐Ÿ“ Milwaukee Medical College of Wisconsin ยท Tests: Venetoclax, Azacitadine, Vorinostat, Cytarabine, Fludarabine Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia NCT06177067Phase 110 sites๐Ÿ“ San Diego๐Ÿ“ Aurora๐Ÿ“ Atlanta St. Jude Children's Research Hospital ยท Tests: Revumenib, Venetoclax, Azacitidine, intrathecal (IT) chemotherapy, Cytarabine
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy